+36.1%
MRNA vs VICR
+209.3%
-173.2%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VICR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +11.2% | -5.8% | +4.5% |
| 7D | -1.1% | +5.0% | -6.0% | -1.5% |
| 30D | +126.1% | -12.5% | +138.6% | +125.3% |
| 3M | +190.0% | -33.6% | +223.6% | +197.0% |
| 6M | +157.2% | +10.7% | +146.6% | +126.6% |
| YTD | +388.2% | +80.6% | +307.6% | +281.9% |
| 1Y | +467.0% | +288.4% | +178.7% | +266.0% |
| 3Y | +36.1% | +213.8% | -177.7% | -19.0% |
| All | +36.1% | +209.3% | -173.2% | -19.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VICR.
Daily Out/Under-Performance
Portfolio return minus VICR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VICR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VICR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling